Muscle health is often discussed as a problem of older age, yet the foundations of later-life strength and independence are built much earlier. During midlife, women may experience changes in physical activity, body composition, sleep, nutrition and ovarian hormone exposure that collectively influence skeletal muscle. Longitudinal evidence suggests that lean mass begins to decline around the menopause transition while fat mass increases, although chronological ageing and lifestyle remain important contributors (Greendale et al., 2019).

This does not mean that every woman entering menopause has sarcopenia. Clinical sarcopenia remains considerably more common in older populations. Instead, midlife should be viewed as a valuable prevention window: maintaining strength and muscle capacity before substantial decline develops may help protect mobility, metabolic health and functional independence later in life (Buckinx & Aubertin-Leheudre, 2022).

What Does Sarcopenia Mean in Midlife?

Sarcopenia is a progressive skeletal-muscle disorder involving impaired muscle strength, muscle quantity or quality and, in more severe cases, reduced physical performance. The European Working Group on Sarcopenia in Older People emphasises low muscle strength as the primary clinical feature. Low strength suggests probable sarcopenia, while reduced muscle quantity or quality confirms the diagnosis; additional impairment in physical performance indicates severe disease (Cruz-Jentoft et al., 2019).

These diagnostic frameworks were primarily developed for older adults. Therefore, a healthy 45- or 50-year-old woman should not automatically be labelled sarcopenic because her lean mass is lower than it was in early adulthood. In midlife physiotherapy, the more useful question is whether muscle capacity is being preserved, maintained or progressively lost.

Muscle loss can also be secondary to physical inactivity, inadequate nutrition, chronic disease or prolonged periods of reduced loading. This makes assessment especially important when weakness appears faster than expected or interferes with normal activities.

Why May Muscle Become More Vulnerable Around Menopause?

Skeletal muscle responds to mechanical loading, nutrition, neural input and hormonal signals. Oestrogen receptors are present within skeletal muscle, and changes in ovarian hormones may influence muscle metabolism, mitochondrial function, inflammation and protein turnover. However, human evidence does not support a simple pathway in which falling oestrogen directly causes sarcopenia in every woman (Menzies et al., 2026).

The Study of Women’s Health Across the Nation demonstrated an important body-composition shift: around the menopause transition, the previous increase in lean mass ceased and lean tissue began to decline, while fat accumulation accelerated (Greendale et al., 2019). More recent reviews similarly suggest that lower muscle or lean mass is commonly observed across peri- and postmenopausal stages, although findings vary between studies and are influenced by age, activity and other health factors (Menzies et al., 2026).

The clinically relevant model is therefore multifactorial:

Menopause transition + ageing + reduced loading + inadequate nutrition + poor recovery or chronic disease → reduced muscle reserve in susceptible individuals.

Hot flushes, disturbed sleep, joint pain, caregiving responsibilities or changes in exercise habits may indirectly reduce training and recovery. The menopause transition should therefore be considered part of the clinical context rather than treated as the sole cause of weakness.

Recognising Declining Muscle Health

The earliest sign may not be visibly smaller muscles. Strength and function can decline before substantial loss of muscle mass becomes obvious.

A physiotherapy assessment should consider the menopause timeline alongside recent changes in activity, body weight, dietary intake, sleep, medication and medical history. Functional complaints such as increasing difficulty rising from a low chair, climbing stairs, carrying groceries, lifting objects or maintaining previous exercise levels deserve attention.

Useful measures may include handgrip strength, repeated sit-to-stand testing, lower-limb strength assessment, gait speed, stair performance and balance. DXA or validated body-composition techniques can provide additional information about lean mass when clinically indicated, but imaging is unnecessary for every healthy midlife woman. Importantly, diagnostic cut-offs developed for geriatric sarcopenia should not be applied mechanically to younger menopausal populations (Cruz-Jentoft et al., 2019; Buckinx & Aubertin-Leheudre, 2022).

Rapid or unexplained weakness, unintended weight loss, repeated falls, marked fatigue, neurological symptoms or disproportionate functional decline warrants medical evaluation. Endocrine, inflammatory, neurological and nutritional causes of weakness should not be attributed to menopause without appropriate assessment.

Resistance Training: The Main Exercise Strategy

Progressive resistance training provides the most direct stimulus for maintaining or increasing muscle strength and size. In middle-aged women, resistance training can substantially improve strength, and studies in postmenopausal populations also demonstrate benefits for physical fitness and body composition (Isenmann et al., 2023; González-Gálvez et al., 2024).

The 2026 American College of Sports Medicine position stand concludes that many forms of resistance training improve strength, hypertrophy and physical function. Training at least twice weekly and progressively challenging the major muscle groups is a central recommendation. Heavier loading can optimise maximal strength, whereas greater weekly training volume becomes more relevant when hypertrophy is a major goal (Currier et al., 2026).

A beginner does not need to start with very heavy weights. Technique, confidence and consistency come first. Over time, however, repeatedly using resistance that is too easy provides little reason for the muscle to adapt. Progressive overload—the gradual increase in training stimulus—is therefore central to muscle preservation (Currier et al., 2026; Ozemek et al., 2025).

Nutrition, Weight Loss and Recovery Matter Too

Exercise cannot fully compensate for inadequate nutrition. Dietary protein supplies the amino acids required for muscle protein synthesis, while resistance exercise sensitises muscle to anabolic stimulation. Protein intake should therefore be adequate and distributed across meals rather than concentrated into a single small portion at the end of the day.

This becomes particularly important during intentional weight loss. Energy restriction can reduce both fat and lean tissue. Experimental work in postmenopausal women shows that protein feeding stimulates muscle protein synthesis during short-term energy restriction, reinforcing the importance of protecting nutritional quality when weight reduction is required (Larsen et al., 2023).

Rather than prescribing the same protein target to every woman, requirements should reflect body size, total energy intake, activity level, health conditions and training goals. Patients with chronic kidney disease or other conditions affecting dietary prescription may require dietetic or medical input.

Sleep and recovery also matter because a programme that cannot be recovered from is difficult to sustain. Aerobic exercise remains valuable for cardiovascular and metabolic health, but it should complement rather than replace resistance training when preservation of muscle is the primary goal.

Menopausal hormone therapy should likewise not be considered a substitute for muscle loading. Evidence regarding its direct effects on muscle mass and sarcopenia remains inconsistent, and decisions regarding hormone therapy should be made for appropriate menopausal indications after individual medical assessment (Buckinx & Aubertin-Leheudre, 2022; Menzies et al., 2026).

Physiotherapy: From Prevention to Progressive Loading

For many women, physiotherapy begins before sarcopenia is present. The goal is to identify declining capacity and build sufficient strength reserve for the decades ahead.

Assessment should establish current strength, previous training experience, functional limitations and barriers to exercise. A sedentary or symptomatic patient may initially require supported sit-to-stands, wall or incline pressing, resistance-band pulling and low-level step work. These exercises can then progress to loaded squats, deadlift variations, split squats, presses, rows and carries as technique and tolerance improve.

Progress should be based on performance rather than age alone. When an exercise becomes consistently comfortable with good technique, the stimulus should increase. Therapeutic exercise principles therefore move from movement competency → resistance tolerance → progressive strength → higher muscle capacity → long-term independent training (Kisner et al., 2023).

Women with osteoporosis, significant joint disease, cardiovascular disease or other clinical conditions may require modified loading and appropriate screening, but these diagnoses do not automatically exclude resistance exercise. Individualisation is more useful than unnecessary restriction.

Viva-Ready Summary

Sarcopenia is characterised primarily by reduced muscle strength, with reduced muscle quantity or quality used to confirm the diagnosis.
Sarcopenia is more common in older adults; menopause does not automatically mean sarcopenia.
The menopause transition may contribute to an environment in which lean mass and muscle reserve become more vulnerable, alongside ageing, inactivity, nutrition and chronic disease.
Strength and functional decline may appear before obvious changes in muscle size.
Progressive resistance training is the principal exercise intervention for preserving muscle strength and mass.
Major muscle groups should generally be trained at least twice weekly, with progressive overload as capacity improves.
Adequate protein and energy intake, recovery and avoidance of unnecessary lean-mass loss during dieting support the training response.
Physiotherapists should assess the whole clinical picture and refer unexplained or disproportionate weakness rather than assuming menopause is the cause.

One-line recall point:
Midlife muscle is preserved by loading it: assess strength early, progressively increase resistance and support training with adequate nutrition and recovery.

References

Buckinx, F., & Aubertin-Leheudre, M. (2022). Sarcopenia in menopausal women: Current perspectives. International Journal of Women’s Health, 14, 805–819. https://doi.org/10.2147/IJWH.S340537

Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., et al. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16–31. https://doi.org/10.1093/ageing/afy169

Currier, B. S., D’Souza, A. C., Fiatarone Singh, M. A., Lowisz, C. V., Rawson, E. S., Schoenfeld, B. J., Smith-Ryan, A. E., Steen, J. P., Thomas, G. A., Triplett, N. T., Washington, T. A., Werner, T. J., & Phillips, S. M. (2026). American College of Sports Medicine position stand: Resistance training prescription for muscle function, hypertrophy, and physical performance in healthy adults: An overview of reviews. Medicine & Science in Sports & Exercise, 58(4), 851–872. https://doi.org/10.1249/MSS.0000000000003897

González-Gálvez, N., Moreno-Torres, J. M., & Vaquero-Cristóbal, R. (2024). Resistance training effects on healthy postmenopausal women: A systematic review with meta-analysis. Climacteric, 27(3), 296–304. https://doi.org/10.1080/13697137.2024.2310521

Greendale, G. A., Sternfeld, B., Huang, M., Han, W., Karvonen-Gutierrez, C., Ruppert, K., Cauley, J. A., Finkelstein, J. S., Jiang, S.-F., & Karlamangla, A. S. (2019). Changes in body composition and weight during the menopause transition. JCI Insight, 4(5), e124865. https://doi.org/10.1172/jci.insight.124865

Isenmann, E., Kaluza, D., Havers, T., Elbeshausen, A., Geisler, S., Hofmann, K., Flenker, U., Diel, P., & Gavanda, S. (2023). Resistance training alters body composition in middle-aged women depending on menopause—A 20-week control trial. BMC Women’s Health, 23, 526. https://doi.org/10.1186/s12905-023-02671-y

Kisner, C., Borstad, J., & Colby, L. A. (2023). Therapeutic exercise: Foundations and techniques (8th ed.). F. A. Davis.

Larsen, M. S., Witard, O. C., Holm, L., Scaife, P., Hansen, R., Smith, K., Tipton, K. D., Mose, M., Bengtsen, M. B., Lauritsen, K. M., Mikkelsen, U. R., & Hansen, M. (2023). Dose-response of myofibrillar protein synthesis to ingested whey protein during energy restriction in overweight postmenopausal women: A randomized, controlled trial. The Journal of Nutrition, 153(11), 3173–3184. https://doi.org/10.1016/j.tjnut.2023.08.011

Menzies, C., Bowtell, R., Shur, N., & Brook, M. S. (2026). Menopause, female sex hormones, skeletal muscle mass and muscle protein turnover in humans. Journal of Cachexia, Sarcopenia and Muscle, 17(1), e70232. https://doi.org/10.1002/jcsm.70232

Ozemek, C., Bonikowske, A. R., Christle, J. W., & Gallo, P. M. (Eds.). (2025). ACSM’s guidelines for exercise testing and prescription (12th ed.). Wolters Kluwer.